ArticleEndocrine, metabolic & immune disorders drug targets2024
Sufficiency of a Single Negative Thyroglobulin Standard for Judging the Success of Ablation in Low- and Intermediate-risk Differentiated Thyroid Cancer: A Retrospective Study.
Yahong Long et al.PubMed ↗Publisher ↗
No numbers read from the abstract.